Lipella Pharmaceuticals News

Lipella Pharmaceuticals Has Completed Dosing For The First Cohort In Its Phase 2A Trial Of LP-310, A Liposomal-tacrolimus Oral Rinse Being Developed For Oral Lichen Planus, Topline Data Is Expected By Year-end And Complete The Trial By Mid-2025

BenzingaNov 21 05:32 ET

Express News | Lipella Pharmaceuticals Inc - Trial Expected to Conclude by Mid-2025 With Top-Line Data by Year-End 2024

ReutersNov 21 05:30 ET

Express News | Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

ReutersNov 21 05:30 ET

Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating

Moomoo NewsNov 20 11:31 ET · Ratings

Maxim Group Keeps Their Buy Rating on Lipella Pharmaceuticals, Inc. (LIPO)

TipRanksNov 20 10:45 ET

Express News | Lipella Pharmaceuticals Inc : Maxim Group Cuts Target Price to $10 From $16

ReutersNov 19 11:10 ET

Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 Loss per Share (Vs US$1.84 Loss in 3Q 2023)

Yahoo FinanceNov 17 08:47 ET

Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges

TipRanksNov 16 01:00 ET

Lipella Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 14 17:31 ET · Announcements

Express News | Lipella Pharmaceuticals Will Be Issued U.S. Patent Number 12,138,345 Tomorrow Titled "DELIVERY OF AGENTS USING METASTABLE LIPOSOMES (FOR THE TREATMENT OF BLADDER CONDITIONS)"

BenzingaNov 11 16:01 ET

Lipella Pharmaceuticals Inc Trading Halted, News Pending

TipRanksNov 7 19:55 ET

Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaNov 7 19:50 ET

Lipella Pharmaceuticals To Carry Out 1-for-8 Reverse Stock Split On November 8th, 2024

Moomoo NewsNov 6 19:40 ET

Express News | Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split

ReutersNov 1 16:30 ET

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference

GlobeNewswireOct 29 08:30 ET

Express News | LIPO shares jump 22% following the announcement of a U.S. Patent allowance for its innovative liposomal drug delivery platform.

Moomoo 24/7Oct 15 05:42 ET

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform

GlobeNewswireOct 15 05:00 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

BenzingaSep 26 16:31 ET

Buy Rating on Lipella Pharmaceuticals Backed by Promising Phase 2a Results for Oral Lichen Planus Treatment

TipRanksSep 25 13:15 ET · Ratings

PRISM MarketView Features Q&A With Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

GlobeNewswireSep 25 08:30 ET